Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

NDAQ:APDN - Post Discussion

Applied DNA Sciences Inc > Something Stinks at APDN
View:
Post by turner20001 on Dec 04, 2023 4:45pm

Something Stinks at APDN

Something Stinks at APDN. Failed CEO Hayward likes to put rush jobs on his press releases well before the results have been tested. One of the biggest debacles at APDN was the press release that APDN would be entering COVID testing. Investors went crazy over this press release. When CEO Hayward released preliminary results of his COVID test to the FDA, they were alarmed. The numbers were not coming out right. APDN's COVID test was making lots of mistakes. The FDA quickly shut down APDN's COVID test. Recently, APDN announced its Monkeypox Test. Once again, investors went crazy over this press release. I strongly suspect APDN has never sold even one Monkeypox test. Now the latest debacle is that APDN's financial statements are wrong, and they could even be way off the mark. APDN's legal and accounting expenses for re-auditing its books could run into the millions of dollars. Believe me, this is going to get the attention of the SEC. But CEO Hayward is not worried. He'll still get his performance bonuses even though he doesn't meet the requirements. All together he'll be making around $1 million a year. Not bad for screwing up a company. It must be nice to ride on the APDN GRAVY TRAIN! Choo Choo Choo and he's laughing all the way to the bank.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities